Fixing Healthcare Podcast

In this week’s episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl balance two sides of American healthcare: the encouraging scientific advances that could help people live longer and healthier lives, and the growing affordability and trust crises threatening patients across the country. The conversation opens on an optimistic note. Dr. Pearl highlights new Yale research showing that aging is far less deterministic than many Americans assume. Rather than a steady and unavoidable decline, the study found that nearly half of adults over 65 improved physically, cognitively or both over a 12-year period. He pairs that story with new cardiovascular guidance from the American College of Cardiology and the American Heart Association, which shifts prevention toward a much longer time horizon and argues that earlier LDL management could prevent a significant share of heart attacks and strokes later in life. The episode then pivots to the mounting financial and institutional pressures facing patients, hospitals and public-health agencies. From rising medical debt and medication nonadherence to declining vaccine trust, hospital cost inflation and the political barriers keeping GLP-1 drugs unaffordable in the United States, the discussion captures both the promise and the fragility of healthcare in 2026. Here are the other major storylines from episode 105: Supplements fail the evidence test: Pearl reviews clinical trial data showing that commonly used supplements such as fish oil, garlic, turmeric, cinnamon and red yeast rice performed no better than placebo in lowering LDL, reinforcing the continued value of lifestyle interventions and low-cost statins. Medical costs continue to destabilize families: New Gallup-linked research shows that 82 million Americans are already making sacrifices to pay medical bills, from skipping meals to delaying retirement. Drug unaffordability worsens medication adherence: A new KFF survey finds that nearly 60% of Americans worry about affording prescriptions, with 43% reporting they have not taken medications as prescribed because of cost. Generative AI adoption surges among physicians: According to a new AMA survey, 81% of doctors now use generative AI in clinical practice, most commonly for documentation, literature summaries and chart support. Hospitals face intensifying economic pressure: The American Hospital Association reports that care delivery costs rose 7.5% last year, driven by higher labor expenses, drug prices, supply inflation and sicker patients. Trust in vaccine authorities continues to erode: Following the legal challenge to RFK Jr.’s overhaul of the federal vaccine advisory committee, new polling shows trust in federal vaccine recommendations has fallen sharply. Newborn preventive care is now affected by distrust: Pearl warns that refusal of vitamin K shots, hepatitis B vaccination and antibiotic eye ointment at birth is rising, reversing decades of scientific progress and reintroducing preventable newborn risks. Alzheimer’s blood tests show progress, but not prediction: New FDA-cleared blood tests can help identify Alzheimer’s disease as the likely cause of current dementia, but Dr. Pearl explains why they remain far less useful for predicting disease years before symptoms begin. The fax machine may finally be dying: In one of the episode’s lighter moments, Dr. Pearl notes that CMS is moving to phase out fax-machine communication across HIPAA-covered entities, a long-overdue modernization step that could save taxpayers nearly $1 billion annually. Residency match reaches record size: The 2026 residency match was the largest in history, with more than 48,000 applicants competing for over 44,000 positions. Early heat waves carry serious health consequences: With unusual March heat across parts of the country, Dr. Pearl explains why early-season heat is especially dangerous, increasing risks of dehydration, kidney injury, cardiovascular strain and mental health emergencies. GLP-1 drugs go generic abroad while U.S. prices stay high: As Novo Nordisk’s blockbuster GLP-1 medications go generic in India and other global markets, Dr. Pearl contrasts international pricing with U.S. costs and argues that congressional inaction on drug pricing remains one of healthcare’s clearest failures. Tune in for more fact-based analysis and practical perspective on the healthcare stories shaping medicine today. * * * Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post MTT #105: New science on aging, rising medical debt & healthcare’s fax problem appeared first on Fixing Healthcare.

Dr. John Whyte, CEO of the American Medical Association and former FDA/CMS leader, shares what physicians and patients are telling him now. He tackles concerns about prior authorization and payment incentives. He explores Medicaid changes risking children’s coverage. He discusses AI and digital health as tools clinicians must steer, plus payment barriers to adopting effective tech.

Jonathan Fisher, cardiologist, mindfulness expert, and author, explains why empathy alone cannot carry healthcare leadership. He explores the need for strategic thinking, operational discipline, and business skills in medicine. Short segments cover burnout’s impact on strategy, why primary care is undervalued, training clinicians in finance and execution, and how attention and flow affect performance under pressure.

They discuss three looming healthcare threats: the coming affordability cliff, the chronic disease crisis, and the risk of training clinicians for the wrong future. Conversation turns to where generative AI stands now and how it could help with chronic care, reduce medical errors, and automate intake and treatment planning. Cultural barriers and early real-world pilots get highlighted as decisive next steps.

They debate a new drug discount program and whether it will actually lower prices. Federal moves to extend telehealth, hospital-at-home pilots and PBM transparency get scrutinized. Rising measles cases, falling trust in vaccine institutions, and new independent vaccine review efforts are discussed. The conversation also touches on mRNA vaccine politics and worrying health trends among younger Americans.

Grace Lynn Keller, VP at Executive Podcast Solutions and former Miss Iowa, speaks as a Gen Z commentator on health, wearables and digital behaviors. She discusses how her generation verifies health info, treats prevention as identity, uses wearables and AI first for nonemergency questions, and expects clearer, more convenient insurance and tech that provides accurate, actionable insights.

Dr. Jonathan Fisher, cardiologist, author and mindfulness expert focused on leadership and burnout prevention. He connects F1 teamwork to medicine. He explores how leadership is learned, how delivery beats content, and how to manage disruptive team members. He also discusses training clinicians for leadership, aligning departments, and planning medical careers in the age of AI.

They dig into Utah’s pilot letting generative AI renew chronic prescriptions without clinician oversight and the legal tug-of-war over regulation. They cover soaring US healthcare spending and how affordability is reshaping coverage. They flag a measles resurgence and rising vaccine-policy battles. They spotlight exercise matching antidepressants for some and AI’s promise for continuous at-home chronic disease monitoring.

This Diving Deep episode with Dr. Robert Pearl and Jeremy Corr looks at U.S. healthcare across three time horizons: past, present and future. The hosts use 2025 as a case study in disruption without reform, 2026 as a year of mounting pressure and near-term transition, and the coming decade as a period when generative AI will fundamentally reshape how medicine is practiced. Looking back at 2025 Dr. Pearl argues that despite political upheaval, executive orders, agency shakeups and constant headlines, American healthcare ended the year largely unchanged. Just more expensive and less trusted. He walks through five domains where chaos dominated but improvement failed to materialize. The throughline? Intense disruption produced little structural change in care delivery, affordability or outcomes. Turning to 2026 The conversation shifts from stagnation to pressure. Pearl identifies two forces that make inaction increasingly risky: the midterm elections and accelerating healthcare costs. He outlines how that pressure is likely to shape behavior across the system — not through sweeping reform, but through targeted, politically visible moves. Looking further ahead Pearl describes how generative AI could alter medicine at a profound level, especially through the convergence of AI and surgical robotics. He argues that autonomous surgery, once the realm of science fiction, is now technologically plausible and could upend long-standing hierarchies between cognitive and procedural specialties. Helpful links Healthcare In 2025: A Year Of Chaos, Confusion — But Little Improvement (Forbes) Healthcare In 2026: How Much Change Should We Expect? (Forbes) Will Your Next Surgeon Be A Robot? (Forbes) Monthly Musings on American Healthcare (RobertPearlMD.com) * * * Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn. The post FHC #204: Why healthcare chaos didn’t lead to change & what comes next appeared first on Fixing Healthcare.

As part of Season 11 of Fixing Healthcare, which spotlights influential voices with large followings and direct insight into how real people experience medicine, Dr. Robert Pearl and Jeremy Corr welcome back medical historian Dr. Lindsey Fitzharris for her third appearance on the show, this time joined by her husband and creative partner, illustrator Adrian Teal. Together, Lindsey and Adrian bring a rare combination of scholarly depth, storytelling and massive digital reach. Lindsey’s work on medical history has captivated millions across books, television and social platforms, while Adrian’s instantly recognizable art has built a massive following online. Their latest collaboration is the children’s book Dead Ends: Flukes, Flops & Failures That Sparked Medical Marvels, which sits at the center of this wide-ranging and unexpectedly personal conversation. The episode begins with a deceptively simple premise: medicine advances not in straight lines but through failure. Lindsey explains her long-standing fascination with scientific dead ends and why medicine often hides them from public view. Dead Ends, she says, was written to show children (and adults) that changing guidance is not a sign of incompetence, but evidence of learning in real time. Adrian adds that humor, exaggeration and even “gross-out” visuals aren’t just entertainment. They’re how curiosity is sparked and how complex medical ideas become memorable. The discussion unfolds across centuries of medical missteps and breakthroughs. Lindsey and Adrian share favorite stories from the book, including early experiments with galvanism, the guillotine’s unexpected medical legacy and how inventions routinely escape the intentions of their creators. One standout example is Martin Couney, an outsider who used a Coney Island sideshow to fund incubator care for premature infants. His invention would go on to save thousands of lives even though the medical establishment initially dismissed the technology. Shifting from history to the present, Lindsey and Adrian reflect on what past failures teach us about regulation, ethics and risk today. While modern safeguards exist for good reason (many historical experiments exploited vulnerable populations) the group wrestles with how to encourage responsible innovation without freezing progress. They also explore how public trust erodes when scientific uncertainty is poorly communicated, especially in a media environment where misinformation travels faster than nuance. The most personal segment arrives when Lindsey discusses her own breast cancer diagnosis, alongside Adrian’s experience with prostate cancer. Their stories ground the episode firmly in Season 11’s focus on lived experience. For listeners interested in how history, art and personal experience illuminate today’s healthcare debates, this episode offers a vivid reminder that progress is rarely tidy and never inevitable. For more unfiltered conversation, listen to the full episode and explore these helpful links. Helpful links Children’s book: Dead Ends: Flukes, Flops & Failures That Sparked Medical Marvels Book: The Butchering Art Book: The Facemaker ChatGPT, MD (Pearl’s newest book)   * * *   Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn. The post FHC #203: Dead ends, failures & the unlikely path to medical progress appeared first on Fixing Healthcare.